Designing Modulators of Monoamine Transporters using Virtual Screening Techniques

Designing Modulators of Monoamine Transporters using Virtual Screening Techniques

The plasma-membrane monoamine transporters (MATs), including the serotonin (SERT), norepinephrine (NET) and dopamine (DAT) transporters, serve a pivotal role in limiting monoamine-mediated neurotransmission through the reuptake of their respective monoamine neurotransmitters. The transporters are th...

Full description

Bibliographic Details
Main Authors:	Ole Valente Mortensen, Sandhya eKortagere
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-09-01
Series:	Frontiers in Pharmacology
Subjects:	serotonin transporter Modeling and simulations Virtual Screening monoamine transporters dopamine transporter norepinephrine transporter
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00223/full

Similar Items

Monoamine transporters: Insights from molecular dynamics simulations
by: Julie eGrouleff, et al.
Published: (2015-10-01)

Amphetamine Derivatives as Monoamine Oxidase Inhibitors
by: Miguel Reyes-Parada, et al.
Published: (2020-01-01)

Handling of intracellular K+ determines voltage dependence of plasmalemmal monoamine transporter function
by: Shreyas Bhat, et al.
Published: (2021-06-01)

Insights to ligand binding to the monoamine transporters – from homology modeling to LeuBAT and dDAT
by: Heidi eKoldsø, et al.
Published: (2015-09-01)

Utilizing Voltage-gated Calcium Channels to Assess the Activity of Cathinone Derivatives at Human Monoamine Transporters
by: Ruiz, Brian A
Published: (2018)

Monoamine Levels and Parkinson’s Disease Progression: Evidence From a High-Performance Liquid Chromatography Study
by: Patsorn Wichit, et al.
Published: (2021-07-01)

Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Retraction]
by: Hinz M, et al.
Published: (2021-03-01)

What mechanisms are responsible for the reuptake of levodopa-derived dopamine in parkinsonian striatum?
by: Haruo Nishijima, et al.
Published: (2016-12-01)

Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)

Serotonin Transporter and Plasma Membrane Monoamine Transporter Are Necessary for the Antidepressant-Like Effects of Ketamine in Mice
by: Melodi A. Bowman, et al.
Published: (2020-10-01)

Big Lessons from Tiny Flies: Drosophila melanogaster as a Model to Explore Dysfunction of Dopaminergic and Serotonergic Neurotransmitter Systems
by: Ameya Sanjay Kasture, et al.
Published: (2018-06-01)

Involvement of organic cation transporter-3 and plasma membrane monoamine transporter in serotonin uptake in human brain vascular smooth muscle cells
by: Rachel Wai-sum Li, et al.
Published: (2013-02-01)

Monoaminergic Modulation of Motor Cortex Function
by: Clément Vitrac, et al.
Published: (2017-10-01)

Computational Model of Antidepressant Response Heterogeneity as Multi-pathway Neuroadaptation
by: Mariam B. Camacho, et al.
Published: (2017-12-01)

Early Rearing Conditions Affect Monoamine Metabolite Levels During Baseline and Periods of Social Separation Stress: A Non-human Primate Model (Macaca mulatta)
by: Elizabeth K. Wood, et al.
Published: (2021-04-01)

Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs)
by: Bruno P. Guiard, et al.
Published: (2011-01-01)

Serotonin uptake via plasma membrane monoamine transporter during myocardial ischemia‐reperfusion in the rat heart in vivo
by: Takashi Sonobe, et al.
Published: (2019-11-01)

Associations of serotonin transporter gene promoter polymorphisms and monoamine oxidase A gene polymorphisms with oppositional defiant disorder in a Chinese Han population
by: Chang-Hong Wang, et al.
Published: (2018-08-01)

Zanthoxylum alatum abrogates lipopolysaccharide-induced depression-like behaviours in mice by modulating neuroinflammation and monoamine neurotransmitters in the hippocampus
by: Chandana Choudhury Barua, et al.
Published: (2018-01-01)

Effects of Hydroxylated Mephedrone Metabolites on Monoamine Transporter Activity in vitro
by: Marco Niello, et al.
Published: (2021-04-01)

Relative Nutritional Deficiencies Associated with Centrally Acting Monoamines [Retraction]
by: Hinz M, et al.
Published: (2020-12-01)

Functional Characterization of the Dopaminergic Psychostimulant Sydnocarb as an Allosteric Modulator of the Human Dopamine Transporter
by: Shaili Aggarwal, et al.
Published: (2021-06-01)

Tyrosine Hydroxylase, Vesicular Monoamine Transporter and Dopamine Transporter mRNA Expression in Nigrostriatal Tissue of Rats with Pedunculopontine Neurotoxic Lesion
by: Lisette Blanco-Lezcano, et al.
Published: (2018-02-01)

Relative Nutritional Deficiencies Associated with Centrally Acting Monoamines [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)

Assessment of Paroxetine Molecular Interactions with Selected Monoamine and γ-Aminobutyric Acid Transporters
by: Magdalena Kowalska, et al.
Published: (2021-06-01)

Reciprocal Interactions Between Monoamines as a Basis for the Antidepressant Response Potential
by: Chernoloz, Olga
Published: (2012)

Reciprocal Interactions Between Monoamines as a Basis for the Antidepressant Response Potential
by: Chernoloz, Olga
Published: (2012)

Reciprocal Interactions Between Monoamines as a Basis for the Antidepressant Response Potential
by: Chernoloz, Olga
Published: (2012)

Reciprocal Interactions Between Monoamines as a Basis for the Antidepressant Response Potential
by: Chernoloz, Olga
Published: (2012)

Conduction states of the human dopamine transporter
by: Cameron, Krasnodara
Published: (2015)

Increased Vesicular Monoamine Transporter 2 (VMAT2) and Dopamine Transporter (DAT) Expression in Adolescent Brain Development: A Longitudinal Micro-PET/CT Study in Rodent
by: Donglang Jiang, et al.
Published: (2019-01-01)

SEX DIFFERENCES IN DOPAMINE REUPTAKE PATHWAYS OF THE NIGROSTRIATAL DOPAMINERGIC SYSTEM IN MICE
by: Bhatt, Sandeep
Published: (2006)

The Discrediting of the Monoamine Hypothesis [Retraction]
by: Hinz M, et al.
Published: (2020-12-01)

A novel missense variant in SLC18A2 causes recessive brain monoamine vesicular transport disease and absent serotonin in platelets
by: Manisha Padmakumar, et al.
Published: (2019-05-01)

The Effect of Organophosphate Exposure on Neocortical, Hippocampal and Striatal Monoamines: A Potential Substrate for Chronic Psychiatric, Cognitive and Motor Dysfunction
by: Lewis, Mary Catherine
Published: (2014)

EXPANDING MONOAMINE TRANSPORTERS PHARMACOLOGY USING CALCIUM CHANNELS
by: Ruchala, Iwona
Published: (2017)

Smoking Related Diseases: The Central Role of Monoamine Oxidase
by: Jean-Marie Launay, et al.
Published: (2011-01-01)

The Discrediting of the Monoamine Hypothesis [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)

Factors that influence the dopamine neuron as revealed by dopamine transporter expression
by: Burke, Mark, 1975-
Published: (2005)

Para-Halogenation Affects Monoamine Transporter Inhibition Properties and Hepatocellular Toxicity of Amphetamines and Methcathinones
by: Dino Luethi, et al.
Published: (2019-04-01)